(Q35917015)

11 August 2017

3 references

11 November 2019

13 November 2019

24 July 2020

The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis (English)

1 reference

11 August 2017

0 references

3 references

11 November 2019

13 November 2019

24 July 2020

1 reference

11 November 2019

1 reference

13 November 2019

1 reference

24 July 2020

R Masekela

1

1 reference

11 August 2017

R J Green

series ordinal

2

1 reference

11 August 2017

language of work or name

1 reference

18 April 2012

4 references

Mediators of Inflammation

11 August 2017

11 November 2019

13 November 2019

24 July 2020

4 references

11 August 2017

11 November 2019

13 November 2019

24 July 2020

2012

1 reference

11 August 2017

134605

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

3 references

11 November 2019

13 November 2019

Bronchiectasis: new approaches to diagnosis and management

24 July 2020

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Mechanisms of action and clinical application of macrolides as immunomodulatory medications

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Inhaled steroids for bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Aerosolized antibiotics for non-cystic fibrosis bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Mucus structure and properties in cystic fibrosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Innate immune activation in neutrophilic asthma and bronchiectasis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Inhaled hyperosmolar agents for bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

New Zealand national incidence of bronchiectasis "too high" for a developed country.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Inhaled fluticasone in bronchiectasis: a 12 month study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Matrix metalloproteinases as modulators of inflammation and innate immunity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Reduction in bronchial subdivision in bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

A study of the pathology and pathogenesis of bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Bronchiectasis in indigenous children in remote Australian communities

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Bronchial diseases and lung aeration in children

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Toll-like receptors and innate immunity.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

The chemotactic activity of sputum from patients with bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Diffuse panbronchiolitis and cystic fibrosis: East meets West

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Bronchiectasis. Third report on a follow-up study of medical and surgical cases from childhood

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Inflammation: a two-edged sword--the model of bronchiectasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis.

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Bronchiectasis in Finland: trends in hospital treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Bronchiectasis: the consequence of late diagnosis in chronic respiratory symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Toll-like receptors stimulate human neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Inhaled steroids improve quality of life in patients with steady-state bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Cells and cytokines in chronic bronchial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Prophylactic antibiotic treatment of bronchiectasis with azithromycin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338115

Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13–induced inflammation and remodeling

24 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F134605

Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group

21 January 2018

1 reference

12 December 2020

Diffuse panbronchiolitis: efficacy of low-dose erythromycin

1 reference

12 December 2020

Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis

1 reference

12 December 2020

Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8

1 reference

12 December 2020

Sputum elastase in steady-state bronchiectasis

1 reference

12 December 2020

A pilot study of low-dose erythromycin in bronchiectasis

1 reference

12 December 2020

A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis

1 reference

12 December 2020

Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells

1 reference

12 December 2020

Bronchiectasis in Alaska Native children: causes and clinical courses

1 reference

12 December 2020

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study

1 reference

12 December 2020

Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells

1 reference

12 December 2020

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/134605

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22570510

1 reference